Press Releases
Feb. 27, 2026
The North/South Chamber Orchestra Performs Music by Five Women Composers on March 5 in New York City
Neutral
EIN Presswire
Jan. 30, 2026
RCP responds to NHS England update on the 10 Point Plan to improve resident doctors’ working lives
Indeterminate
Royal College of Physicians
Owner: Royal College of Physicians (Non-profit)
Jan. 29, 2026
Analysis reveals Poverty in UK has Worsened
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Jan. 30, 2026
CGTN: Beyond differences: Why the British PM calls long-awaited China trip a 'huge opportunity'
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Citipost Mail Achieves Investors in People Platinum Following Exceptional Assessor Review
Neutral
EIN Presswire
Feb. 24, 2026
Business Reporter: Improving efficiency to build smoother customer journeys
Neutral
EIN Presswire
Feb. 27, 2026
Endeavour Silver Announces Q4 2025 Financial Results; Earnings Call at 10AM PST (1PM EST) Today
Indeterminate
GlobeNewswire, Inc.
Feb. 24, 2026
Luware modernises SIX’s financial market communications with cloud-native efficiency and compliance
Neutral
EIN Presswire
Feb. 26, 2026
Zscaler Announces Strong Second-Quarter Fiscal 2026 Results; Raises Fiscal 2026 ARR Guidance to 24%
Indeterminate
GlobeNewswire, Inc.
Feb. 26, 2026
Aura Announces Q4 2025 and FY 2025 Financial and Operational Results
Indeterminate
GlobeNewswire, Inc.
Feb. 27, 2026
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
Feb. 26, 2026
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
Indeterminate
GlobeNewswire, Inc.
Feb. 23, 2026
saVRee Launches Maritime Training Courses to Build Digital Competency Across Marine and Offshore Operations
Neutral
EIN Presswire
Feb. 25, 2026
BizClik Returns With CPD-Accredited Procurement & Supply Chain LIVE and Sustainability LIVE: The Net Zero Summit
Indeterminate
GlobeNewswire, Inc.
Feb. 26, 2026
EpicQuest Education Enters into MOU to Offer its Masters in Management Program in the South Asia Market
Indeterminate
GlobeNewswire, Inc.
Feb. 26, 2026
Court minutes from 2023 that were previously redacted
Gov't Institution
Bank of England
Owner: British Government
Feb. 26, 2026
FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option
Indeterminate
GlobeNewswire, Inc.